3,4-dihydroxyphenylethanol has been researched along with transforming growth factor beta in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cheng, Y; Fei, J; Fu, X; Jiang, Q; Qu, Z | 1 |
Alisi, A; Bianchi, M; Braghini, MR; Comparcola, D; Condorelli, AG; Conti, LA; Crudele, A; De Stefanis, C; Gurrado, F; Lioci, G; Mosca, A; Nobili, R; Panera, N; Sartorelli, MR; Scoppola, V; Smeriglio, A; Svegliati-Baroni, G; Trombetta, D | 1 |
Batarfi, WA; Hamid, AA; Mohd Yunus, MH | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylethanol and transforming growth factor beta
Article | Year |
---|---|
Hydroxytyrosol contributes to cell proliferation and inhibits apoptosis in pulsed electromagnetic fields treated human umbilical vein endothelial cells in vitro.
Topics: Apoptosis; Biomarkers; Cell Movement; Cell Proliferation; Electromagnetic Fields; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Mitochondria; Phenylethyl Alcohol; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2017 |
Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis.
Topics: Animals; Carbon Tetrachloride; Fibrosis; Liver; Liver Cirrhosis; Mice; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; Reactive Oxygen Species; Transcription Factors; Transforming Growth Factor beta; Vitamin E | 2022 |
The Effect of Hydroxytyrosol in Type II Epithelial-Mesenchymal Transition in Human Skin Wound Healing.
Topics: Cell Movement; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2023 |